Cargando…
Multiplexed engineering and precision gene editing in cellular immunotherapy
The advent of cellular immunotherapy in the clinic has entirely redrawn the treatment landscape for a growing number of human cancers. Genetically reprogrammed immune cells, including chimeric antigen receptor (CAR)-modified immune effector cells as well as T cell receptor (TCR) therapy, have demons...
Autores principales: | Biederstädt, Alexander, Manzar, Gohar Shahwar, Daher, May |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723254/ https://www.ncbi.nlm.nih.gov/pubmed/36483551 http://dx.doi.org/10.3389/fimmu.2022.1063303 |
Ejemplares similares
-
Engineering the next generation of CAR-NK immunotherapies
por: Biederstädt, Alexander, et al.
Publicado: (2021) -
Engineered TCR-T Cell Immunotherapy in Anticancer Precision Medicine: Pros and Cons
por: Zhao, Qijie, et al.
Publicado: (2021) -
Precision Immunotherapy for Sepsis
por: Peters van Ton, Annemieke M., et al.
Publicado: (2018) -
Multiplex precise base editing in cynomolgus monkeys
por: Zhang, Wenhui, et al.
Publicado: (2020) -
Commentary: Precision Immunotherapy for Sepsis
por: Zijlstra, Jan G., et al.
Publicado: (2019)